Genomic Approaches in Breast Cancer Management
Author Information
Author(s): Chang J C, Hilsenbeck S G, Fuqua S A W
Primary Institution: Baylor College of Medicine
Hypothesis
Can genomic profiling improve the prediction of breast cancer outcomes and treatment responses?
Conclusion
Recent advancements in microarray technology may enhance the ability to predict long-term outcomes for breast cancer patients.
Supporting Evidence
- Microarray technologies can measure RNA expression of thousands of genes simultaneously.
- Studies have shown that gene expression profiles can predict treatment responses.
- Current standard prognostic factors are not sufficient for accurate individual outcome predictions.
Takeaway
Scientists are using new technology to look at many genes at once to help doctors understand breast cancer better and decide on the best treatments.
Methodology
The review discusses the application of microarray technologies to analyze gene expression in breast cancer.
Potential Biases
Potential biases due to small sample sizes and the complexity of gene expression data.
Limitations
Many studies have small sample sizes and may not include all relevant clinical parameters.
Participant Demographics
The studies reviewed include young breast cancer patients, both node-negative and node-positive.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website